GV 2019, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-02-06
4:32 pm
Sale		2025-12-3113GMAZE THERAPEUTICS INC
MAZE		GV 2019, L.P.1,388,583
2.900%		-1,023,888decrease
(-42.44%)		Filing
History
2025-11-12
4:30 pm
Purchase		2025-09-3013GPRIME MEDICINE INC
PRME		GV 2019, L.P.16,562,498
12.300%		1,500,000increase
(+9.96%)		Filing
History
2025-05-09
4:15 pm
Purchase		2025-03-3113GMAZE THERAPEUTICS INC
MAZE		GV 2019, L.P.2,412,471
5.500%		2,412,471increase
(New Position)		Filing
History
2024-11-08
4:18 pm
Sale		2024-09-3013GINVIVYD, INC.
IVVD		GV 2019, L.P.0
0.000%		-5,680,785decrease
(Position Closed)		Filing
History
2024-02-29
4:15 pm
Purchase		2024-02-2013GPRIME MEDICINE INC
PRME		GV 2019, L.P.15,062,498
12.200%		3,200,000increase
(+26.98%)		Filing
History
2024-02-09
4:09 pm
Sale		2023-12-3113GPRIME MEDICINE INC
PRME		GV 2019, L.P.11,862,498
12.200%		-1,422,190decrease
(-10.71%)		Filing
History
2023-02-10
4:05 pm
Purchase		2022-12-3113GPRIME MEDICINE INC
PRME		GV 2019, L.P.13,284,688
13.700%		13,284,688increase
(New Position)		Filing
History
2022-02-14
12:36 pm
Purchase		2021-12-3113GEQRX INC
EQRX		GV 2019, L.P.47,252,687
9.690%		47,252,687increase
(New Position)		Filing
History
2022-02-14
12:30 pm
Purchase		2021-12-3113GINVIVYD, INC.
IVVD		GV 2019, L.P.5,680,785
5.110%		5,680,785increase
(New Position)		Filing
History